Jul 28, 2015
|
MGD011 Advances Into Clinical Development
|
|
Jul 14, 2015
|
MacroGenics Announces Pricing of Public Offering of Common Stock
|
|
Jul 13, 2015
|
MacroGenics Announces Proposed Public Offering of Common Stock
|
|
May 30, 2015
|
MacroGenics Presents Updated Data from Phase 1 Study of Margetuximab at ASCO Annual Meeting 2015
|
|
May 27, 2015
|
MacroGenics Preclinical Research on MGD006 DART(R) Molecule Published in Science Translational Medicine
|
|
May 13, 2015
|
MacroGenics Announces Presentation at ASCO Annual Meeting 2015
|
|
May 06, 2015
|
MacroGenics Provides Update on Corporate Progress and First Quarter 2015 Financial Results
|
|
Apr 29, 2015
|
MacroGenics Announces Date of First Quarter 2015 Financial Results Conference Call
|
|
Apr 28, 2015
|
MacroGenics Announces Participation in Two Investor Conferences in May
|
|
Apr 20, 2015
|
MacroGenics Presents Pre-Clinical Data on its Multivalent DR5 DART at the AACR Annual Meeting
|
|
Apr 16, 2015
|
MacroGenics Announces Presentations at AACR Annual Meeting 2015
|
|
Apr 07, 2015
|
MacroGenics to Present at the 14th Annual Needham Healthcare Conference
|
|
Mar 16, 2015
|
MacroGenics Initiates Phase 1 Study of MGD010 for the Treatment of Autoimmune Disorders
|
|
Mar 03, 2015
|
MacroGenics Provides Update on Corporate Progress and 2014 Financial Results
|
|
Mar 02, 2015
|
MacroGenics to Present at the Roth Capital Partners 27th Annual Growth Stock Conference
|
|
Feb 24, 2015
|
MacroGenics Announces Date of Fourth Quarter and Full Year 2014 Financial Results Conference Call
|
|
Feb 05, 2015
|
MacroGenics to Present at the Leerink Global Healthcare Conference
|
|
Jan 27, 2015
|
MacroGenics Announces Closing of Collaboration and License Agreement with Janssen to Develop MGD011 for Multiple B-Cell Malignancies
|
|
Jan 12, 2015
|
MacroGenics to Present at the 33rd Annual J.P. Morgan Healthcare Conference
|
|
Dec 22, 2014
|
MacroGenics Enters Collaboration and License Agreement with Janssen to Develop MGD011 for Multiple B-Cell Malignancies
|
|
Dec 06, 2014
|
MacroGenics Announces Presentation of Pre-clinical Data on new DART(r) Candidate MGD011 at 56th Annual Meeting of the American Society of Hematology
|
|
Dec 03, 2014
|
MacroGenics to Present at the Oppenheimer 25th Annual Healthcare Conference
|
|
Nov 12, 2014
|
MacroGenics to Present at the Stifel 2014 Healthcare Conference
|
|
Nov 11, 2014
|
MacroGenics Provides Update on Corporate Progress and Third Quarter 2014 Financial Results
|
|
Nov 06, 2014
|
MacroGenics Announces Pre-clinical Data to be Presented at ASH 2014 Annual Meeting
|
|